Clinical Trial Search

Primary: 6 Month Progression Free Survival (PFS) — 2.8; NA Months

Primary: Change in SARS-COV-2 Viral Load — 6.5; 6.5; 4.4; 3.7 log10 copies/mL — p=0.06

Primary: Number of Participants Who Experienced Net Adverse Clinical Events (Adjudicated Data) Based on ISTH Criteria in Participants Taking Edoxaban vs VKA — 170; 157…

Primary: Mean Length of Hospital Stay — 44.91; 50.50 hours

Primary: BVCA Utilizing Refraction Results From Handheld Device Compared to Manual Refraction Methods for the Age Stratum 45 Through 65 Years — 0.06; 0.02; 0.03 logMAR

Primary: Percentage of Participants Who Die or Require Non-Invasive Ventilation/High-Flow Oxygen or Invasive Mechanical Ventilation (Including Extracorporeal Membrane Oxygenation…

Primary: Number of Sepsis Patients With 30 Days Mortality — 377; 424; 3217; 3389 Participants — p=0.24

Primary: Intentions to Use the Parenting Young Children Check-up Web-based Resource: Quantitative — 3.25 score on a scale

Primary: Percent Change in D-dimer — -5.6; -2.4 percent daily change — p=0.24

Primary: Number of Participants With Solicited Local Reactions at the Injection Site (Pain, Tenderness, Erythema/Redness, Induration/Swelling) Recorded up to 7 Days After Each…

Primary: Montgomery-Asberg Depression Rating Scale (MADRS) — 16 units on a scale

Primary: Number of Participants With Dose Limiting Toxicity (Phase 1 Only) — 0; 0; 0; 0 participants

Primary: Satisfaction With Anesthesia Assessed by the ISAS — 2.4; 2.2 score on a scale

Primary: Serious Adverse Reactions (SARs), Severe AEs and Important Medical Reactions (IMRs) Incidence — 0; 1; 0; 5 participants

Primary: Percentage Change From Baseline (Week 0) to Week 104 in Body Weight — -15.9; -1.9; -17.3; -2.0 percentage change — p=<.0001